Eintrag weiter verarbeiten

Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Pos...

Gespeichert in:

Veröffentlicht in: Journal of clinical oncology 30(2012), 35, Seite 4323-4329
Personen und Körperschaften: Branford, Susan (VerfasserIn), Müller, Martin Christian (VerfasserIn)
Titel: Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib/ Susan Branford, Dong-Wook Kim, Simona Soverini, Ariful Haque, Yaping Shou, Richard C. Woodman, Hagop M. Kantarjian, Giovanni Martinelli, Jerald P. Radich, Giuseppe Saglio, Andreas Hochhaus, Timothy P. Hughes, and Martin C. Müller
Format: E-Book-Kapitel
Sprache: Englisch
veröffentlicht:
2012
Gesamtaufnahme: : Journal of clinical oncology, 30(2012), 35, Seite 4323-4329
, volume:30
Erscheint auch als: Branford, Susan, Initial molecular response at 3 months may predict both response and event-free survival at 24 months in imatinib-resistant or -intolerant patients with philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with nilotinib, 2012
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen